Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 30, 2023
A EUFOREA comment on a lost comorbidity of asthmaDiego M Conti, Peter W Hellings, Zuzana Diamant, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 4, 2003
Predominance of rhinovirus in the nose of symptomatic and asymptomatic infantsInesz van Benten, Laurens Koopman, Bert Niesters, et al.
Cephalalgia : an International Journal of Headache|April 25, 2026
Proposed changes to current definitions of ICHD-3 regarding headache and facial pain attributed to the disorder of the nose or paranasal sinusesMarcin Straburzyński, Adrian M Agius, Claire Hopkins, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 10, 2018
Dietary patterns and respiratory health in adults from nine European countries-Evidence from the GA<sup>2</sup> LEN studyIoannis Bakolis, Richard Hooper, Claus Bachert, et al.
Journal of Patient-Reported Outcomes|January 20, 2023
Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE studyWytske Fokkens, Andrew Trigg, Stella E Lee, et al.
The Journal of Allergy and Clinical Immunology|May 11, 2010
Oral steroids and doxycycline: two different approaches to treat nasal polypsThibaut Van Zele, Philippe Gevaert, Gabriele Holtappels, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 26, 2024
Dupilumab Versus Mepolizumab for Chronic Rhinosinusitis With Nasal Polyposis: An Indirect Treatment ComparisonClaire Hopkins, Joseph K Han, Wytske Fokkens, et al.
Clinical and Translational Allergy|October 29, 2015
A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 CongressPeter W Hellings, Antonella Muraro, Wytske Fokkens, et al.
Expert Review of Clinical Immunology|May 25, 2023
Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision makingJosje Otten, Rik van der Lans, Eugenio de Corso, et al.
International Forum of Allergy & Rhinology|August 7, 2023
Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS-24 and SINUS-52Claus Bachert, Asif H Khan, Stella E Lee, et al.
Pageof 7